Posted on 3/15/18
Torque Appoints John Hohneker, MD, to Board of Directors and Marcela Maus, MD, PhD, to Scientific Advisory Board
Torque, an immuno-oncology company developing Deep Primed cell therapeutics with pharmacologic control to drive a full immune response within the tumor
Posted on 3/15/18
City Year Names David L. Cohen and Jonathan S. Lavine Co-Chairs of its National Board of Trustees
City Year, an education nonprofit fueled by national service that helps students and schools to succeed, announced today that David L. Cohen
Posted on 3/14/18
Great Point Partners-backed Citra Health Solutions Appoints Scott Sanner as CEO
Great Point Partners II portfolio company, Citra Health Solutions, a trusted provider of benefit administration
Posted on 3/13/18
Goldfinch Bio Appoints Dr. Peter Mundel as Chief Scientific Officer and Elects Dr. Frank Maddux to Board
Goldfinch Bio, a company focused on precision therapies to treat patients with kidney disease, today announced the strengthening of its leadership team with the election of . . .
Posted on 3/13/18
Adriane M. Brown Elected to Raytheon Board of Directors
The board of directors of Raytheon Company (NYSE: RTN) has elected Adriane M. Brown as a director
Posted on 3/13/18
James R. Tobin Joins Corindus Board of Directors
Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that James (Jim) Tobin
Posted on 3/13/18
Watts Water Technologies Elects Louise K. Goeser to Board
Watts Water Technologies, Inc. (NYSE: WTS) today announced the election of Louise K. Goeser as a member of the Board of Directors.
Posted on 3/12/18
Epizyme Appoints Michael Giordano, M.D., to its Board of Directors
Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the appointment of Michael Giordano, M.D.,
Posted on 3/9/18
Amy Coyne joins Wild Things as CEO
Wild Things, LLC, an ASGARD Partners & Co. portfolio company, announced that industry veteran Amy Coyne has joined as Chief Executive Officer.
Posted on 3/9/18
Tango Therapeutics Expands Board of Directors
Tango Therapeutics, a biotechnology company creating novel, targeted medicines for specific cancer subtypes, today announced the addition of three experienced leaders
Posted on 3/9/18
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that it has added to its Board of Directors, expanded its clinical leadership team, and established a Scientific Advisory . . .
Posted on 3/7/18
Partner Therapeutics Appoints Ellen Hukkelhoven Ph.D. and Terry Gould to its Board of Directors
Boston-based cancer company Partner Therapeutics, Inc. (PTx) announced today the appointment of Ellen Hukkelhoven and Terry Gould to the company's Board of Directors.
Posted on 3/7/18
Connecticut Water Service Names David C. Benoit CEO
The board of directors of Connecticut Water Service Inc. (CTWS or the company) announced today that David C.
Posted on 3/6/18
Disarm Therapeutics Expands Scientific Advisory Board
Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration
Posted on 3/6/18
BioDirection Appoints Dr. Harry E. Rubash as Chairman of Medical Advisory Board
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management
Posted on 3/6/18
Houghton Mifflin Harcourt Appoints Jean S. Desravines to Board of Directors
Global learning company Houghton Mifflin Harcourt (HMH) today announced that Jean S. Desravines, CEO of the national education nonprofit New Leaders
Posted on 3/5/18
Joseph Darling Named CEO and Director of Anika Therapeutics
Anika Therapeutics, Inc.(NASDAQ:ANIK) today announced the appointment of Joseph Darling as Chief Executive Officer
Posted on 3/5/18
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections
Posted on 3/5/18
YMCA of Greater Boston Adds Kathy deCastro as Member of the General Board
The YMCA of Greater Boston and Sun Life Financial U.S. are pleased to announce that Kathy deCastro
Posted on 3/5/18
REZ-1 Appoints Pervinder Johar as CEO
REZ 1, Inc. (REZ-1), a leading provider of technology and services to the global logistics and transportation industry, is pleased to announce the appointment of Pervinder . . .
Posted on 3/5/18
Kala Pharmaceuticals Appoints Gregory Perry to Board of Directors and as Audit Committee Chair
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary
Posted on 3/5/18
PAREXEL Appoints Jamie Macdonald as CEO
PAREXEL International Corporation, the world's leading innovator of biopharmaceutical services, today announced the
Posted on 3/2/18
Unum Therapeutics Appoints Karen Ferrante and Robert Perez to Board
Unum Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products designed to harness
Posted on 3/2/18
Exogenesis Corp. Appoints Dmitry Shashkov as CEO
The Board of Directors of Exogenesis Corporation is pleased to announce the appointment of Dmitry Shashkov, Ph.D. as President and Chief Executive Officer.
Posted on 2/28/18
Frank Palumbo Joins SevOne’s Board of Directors
SevOne, a leading provider of network and infrastructure management solutions, today announced that Frank Palumbo, senior vice president of Worldwide Data Center
Boston
